Complementation analysis in patients with the clinical phenotype of a generalised peroxisomal disorder

Journal of Medical Genetics

Volumn 33, Issue 4, 1996, Pages 295-299

  Steinberg, Steven J ^a   Fensom, Anthony H ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Generalised peroxisomal disorder; Peroxisomal bifunctional protein; PXR1

Indexed keywords

CATALASE; PLASMALOGEN; PROTEIN; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CELL HYBRIDIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF PEROXISOMAL FUNCTIONS; FETUS; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; OXIDATION; PEROXISOME; PHENOTYPE; PRIORITY JOURNAL; REFSUM DISEASE; SKIN FIBROBLAST; SOLUBILITY; SOMATIC CELL; ZELLWEGER SYNDROME;

EID: 0029878245     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.33.4.295     Document Type: Article

References (20)

1. Lazarow PB, Moser HW. Disorders of peroxisome biogenesis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. New York: McGraw Hill, 1995:2287-324.
2. Poll-The BT, Roels F, Ogier H, et al. A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am J Hum Genet 1988;42:422-34.
3. Watkins PA, Chen WW, Harris CJ, et al. Peroxisomal bifunctional enzyme deficiency. J Clin Invest 1989;83:771-77.
4. Schram SW, Goldfischer S, van Roermund CWT, et al. Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc Natl Acad Sci USA 1987;84:2494-6.
5. McGuiness MC, Moser AB, Poll-The BT, Watkins PA. Complementation analysis of patients with intact peroxisomes and impaired peroxisomal oxidation. Biochem Med Metab Biol 1993;49:228-12.
6. Shimozawa N, Sizuki Y, Orii T, et al. Standardization of complementation grouping of peroxisome deficient disorders and the second Zellweger syndrome patient with peroxisomal assembly factor-1 (PAF-1) defect. Am J Hum Genet 1993;52:843-4.
7. Moser AB, Rasmussen M, Naidu S, et al. Phenotype of 173 peroxisome disorder patients subdivided into 16 complementation groups. J Pediatr 1995;127:13-22.
8. Wiemer EAC, Out M, Schelen A, et al. Phenotypic heterogeneity in skin fibroblasts from patients with disorders of peroxisome biogenesis belonging to the same complementation group. Biochim Biophys Acta 1991;1097:212-7.
9. Slawecki ML, Dodt G, Steinberg S, et al. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. J Cell Sci 1995;108:1817-29.
10. Gärtner J, Moser H, Valle D. Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome. Nature Genet 1992;1:16-23.
11. Braverman N, Dodt G, Gould SJ, Valle D. Disorders of peroxisome biogenesis. Hum Mol Genet 1995;4:1791-8.
12. Tsukamoto T, Miura S, Fujiki Y. Restoration by a 35K membrane protein of peroxisome assembly in a peroxisome-deficient mammalian cell mutant. Nature 1991;350:77-81.
13. Dodt G, Braverman N, Wong C, et al. Mutations in the PTSE receptor gene, PXRI, define complementation group 2 in the peroxisome biogenesis disorders. Nature Genet 1995;9:115-25.
14. Steinberg SJ, Ward CP, Fensom AH. Complementation studies in Niemann-Pick disease type C indicate the existence of a second group. J Med Genet 1994;31:317-20.
15. Roscher A, Molzer B, Bernheimer H, et al. The cerebrohepatorenal (Zellweger) syndrome: an improved method for the biochemical diagnosis and its potential value for prenatal detection. Pediatr Res 1985;19:930-3.
16. Moser HW, Moser AB. Measurement of saturated very long chain fatty acids in plasma. In: Hommes FA, ed. Techniques in diagnostic human biochemical genetics. New York: Wiley-Liss, 1991:177-92.
17. Lazarow PB, Fujiki Y, Small GM, Watkins P, Moser H. Presence of the peroxisomal 22-kDa integral membrane protein in the liver of a person lacking recognizable peroxisomes (Zelhveger syndrome). Proc Nad Acad Sci USA 1986;83:9193-6.
18. Watkins PA, Ferrell EV, Pederson JI, Hoefler G. Peroxisomal fatty acid β oxidation in HepG2 cells. Arch Biochcm Biophys 1991;289:329-36.
19. Steinberg SJ, Fensom AH, Dalton NR, et al. Measurement of plasma very long-chain fatty acids as a preliminary screening procedure for the diagnosis of peroxisomal disorders. J Inher Metab Dis 1994;17:323-6.
20. Hoefler G, Forstner M, McGuiness MC, et al. cDNA cloning of the human peroxisomal enoyl-CoA hydratase: 3-hydroxyacyl-CoA dehydrogenase bifunctional eruyme and localization to chromosome 3q26.3-3q28: a free left Alu arm is inserted in the 3′ noncoding region. Genomics 1994;19:60-7.